Study on aneuploidy and p53 mutations in astrocytomas

Cancer Genetics and Cytogenetics

Volumn 88, Issue 2, 1996, Pages 95-102

  Campomenosi, Paola ^a   Ottaggio, Laura ^a   Moro, Francesca ^a   Urbini, Stefania ^a   Bogliolo, Massimo ^a   Zunino, Annalisa ^a   Camoriano, Annalisa ^a   Inga, Alberto ^a   Gentile, Salvatore L ^a   Pellegata, Natalia S ^b   Bonassi, Stefano ^a   Bruzzone, Eros ^a   Iannone, Raffaella ^a   Pisani, Roberto ^a   Menichini, Paola ^a   Ranzani, Guglielmina N ^b   Bonatti, Stefania ^a,c   Abbondandolo, Angelo ^a,c   Fronza, Gilberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ANEUPLOIDY; ARTICLE; ASTROCYTOMA; CHROMOSOME 10; CHROMOSOME 17; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA SEQUENCE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029950933     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(95)00359-2     Document Type: Article

References (45)

1. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD (1992): Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935.
2. Bischoff FZ, Yim SO, Pathak S, Grant G, Siciliano MJ, Giovanella BC, Strong LC, Tainsky MA (1990): Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: Aneuploidy and immortalization. Cancer Res 50:7979-7984.
3. Blount PL, Galipeau PC, Sanchez CA, Neshat K, Levine DS, Yin J, Suzuki H, Abraham JM, Meltzer SJ, Reid BJ (1994): 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res 54:2292-2295.
4. Neshat K, Sanchez CA, Galipeau PC, Blount PL, Levine DS, Joslyn G, Reid BJ (1994): p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology 106:1589-1595.
5. Danova M, Giaretti W, Merlo F, Mazzini G, Gaetani P, Geido E, Gentile S, Butti G, Di Vinci A, Riccardi A (1991): Prognostic significance of nuclear DNA content in human neuroepithelial tumors. Int J Cancer 48:663-667.
6. Louis ND (1994): The p53 gene and protein in human brain tumors. J Neuropathol Exper Neurol 53:11-21.
7. Kleihues P, Burger P and Scheinthauer BW (eds) (1993): Histological typing of tumors of the central nervous system. Berlin: Spring-Verlag.
8. James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold N, Collins VP, Cavenee WK (1988): Clonal genomic alterations in glioma malignancy stages. Cancer Res 48:5546-5551.
9. Fults D, Tippets RH, Thomas GA, Nakamura Y, White R (1989): Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. Cancer Res 49:6572-6577.
10. Spurr NK, Solomon E, Jansson M, Sheer D, Goodfellow PM, Bodmer WF, Vennstrom B (1984): Chromosomal localization of the human homologue to oncogenes erbA and B. EMBO J 3:159-163.
11. Börresen AL, Hovig E, Smith-Sörensen B, Malkin D, Lystad S, Andersen TI, Nesland JM, Isselbacher KJ, Friend SH (1991): Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc Natl Acad Sci USA 88:8405-8409.
12. Renault B, van Der Broek M, Fodde R, Wijnen J, Pellegata NS, Amadori D, Meera Khan P, Ranzani GN (1993): Base transitions are the most frequent genetic changes at p53 in gastric cancer. Cancer Res 53:2614-2617.
13. Sheffield VC, Cox DR, Lerman L, Myers RM (1989): Attachment of a 40-base-pair G+C rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single base changes. Proc Natl Acad Sci USA 86:232-236.
14. Arnoldus EPJ, Noordermeer IA, Peters ACB, Voormolen JHC, Bots GTAM, Raap AK, van der Ploeg M (1991): Interphase cytogenetics of brain tumors. Genes Chrom Cancer 3:101-107.
15. Pinkel D, Straume T, Gray JW (1986): Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 83:2934-2938.
16. Cox DR, Oakes D (1965): Analysis of survival data - Proportional hazards model. London, Chapman and Hall.
17. Norusis MJ (1992): SPSS for Windows, User's Guide. Release 5.0 SPSS Inc. Chicago
18. Baker RJ, Neider JA (1978): The GLIM system. Release 3. Numerical Algorithms Group, Oxford.
19. Eastmond DA, Pinkel D (1989): Aneuploidy detection by analysis of interphase nuclei using fluorescence in situ hybridization with chromosome-specific probes. In: Resnick MA, Vig BK (eds): Mechanisms of chromosome distribution and aneuploidy. New York, Alan Liss, Inc, pp. 277-284.
20. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B (1992): Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256:827-830.
21. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM (1992): p53 mutations and loss of heterozygosity on chromosome 17 and 10 during human astrocytoma progression. Cancer Res 52:674-679.
22. Chung RY, Whaley J, Kley N, Anderson K, Louis D, Menon A, Hettlich C, Freiman R, Hedley-Whyte ET, Martuza R, Jenkins R, Yandel D, Seizinger BR (1991): TP53 mutations and 17p deletion in human astrocytomas. Genes Chrom Cancer 3:323-331.
23. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B (1992): Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 355:846-847.
24. Lang FF, Miller DC, Pisharody S, Koslow M, Newcomb EW (1994): High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Oncogene 9:949-954.
25. Del Arco A, Garcia J, Arribas C, Barrio R, Blazquez MG, Izquierdo JM, Izquierdo M (1993): Timing of p53 mutations during astrocytoma tumorigenesis. Hum Mol Gen 2:1687-1690.
26. Kraus JA, Bolin C, Wolf HK, Neumann J, Kindermann J, Fimmers R, Forster F, Baumann A, Schlegel (1994): TP53 alterations and clinical outcome in low grade astrocytomas. Genes Chrom Cancer 10:143-149.
27. Kyritsis AP, Saya H (1993): Epidemiology, cytogenetics, and molecular biology of brain tumors. Current Opin in Oncol 5:474-480.
28. Chozick BS, Weicker E, Pezzullo JC, Jackson CL, Finkelstein SD, Ambler MW, Epstein MH, Finch PW (1994): Pattern of mutant p53 expression in human astrocytomas suggests the existence of alternate pathways of tumorigenesis. Cancer 73:406-414.
29. Barlogic B, Raber MN, Schumann J, Johnson TS, Drewinko B, Swartzendruber DE, Gohde W, Andreeff M, Freireich EJ (1983): Flow cytometry in clinical cancer research. Cancer Res 43:3982-3997.
30. Van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF, Cairncross JG (1994): p53 mutation, expression, and DNA ploidy in evolving gliomas: Evidence for two pathways of progression. J Natl Cancer Inst 86:1011-1017.
31. Mendelsohn ML, Mayall BH, Bogart E, Moore II DH, Perry BH (1973): DNA content and DNA-based centromeric index of the 24 human chromosomes. Science 179:1126-1129.
32. Pershouse MA, Stubblefield E, Hadi A, Killary AM, Yung WKA, Steck PA (1993): Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res 53:5043-5050.
33. Bello MJ, De Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana AA, Rev JA (1984): Molecular analysis of genomic abnormalities in human gliomas. Cancer Genet Cytogenet 73:122-129.
34. Fults D, Pedone CA (1993): Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chrom Cancer 7:173-177.
35. Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Ali IU (1992): Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Res 52:6716-6721.
36. Frankel RH, Bayona W, Koslow M, Newcomb EW (1992): p53 mutations in human malignant gliomas: Comparison of loss of heterozygosity with mutation frequency. Cancer Res 52: 1427-1433.
37. Von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, Kleihues P, Chung RY, Wiestler OD, Seizinger BR (1992): p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res 52:2987-2990.
38. Evans HJ (1985): Neoplasia and cytogenetic abnormalities. In: Dellarco WL, Voytek PE, Hollaender A (eds): Aneuploidy. Ethiology and mechanisms. New York: Plenum Press, pp. 165-178.
39. Arnoldus EPJ, Wolters LBT, Voormolen JHC, van Duinen SG, Raap AK, van der Ploeg M, Peters ACB (1992): Interphase cytogenetics: A new tool for the study of genetic changes in brain tumors. J Neurosurg 76:997-1003.
40. Benabid AL, Chauvin C, Chaffanet M, Rost N, Laine M, Nissou MF (1989): Oncogenes and brain tumors, In: Bolla ME, Chambaz C, Vrousos C (eds): Growth Factors and Oncogenes, vol 190 Colloque INSERM/John Libbey Eurotex Ltd., pp. 209-220.
41. Talarico D, Raimondi E, Fognani C, Gerosa MA, Gregotti S, Della Valle G, De Carli L (1987): Increased number of chromosome 7 is related to overexpression of EGF receptor gene in human glioblastomas. Cytotechnology 1:41-46.
42. Mertens F, Johansson B, Mitelman F (1994): Isochromosomes in neoplasia. Genes Chrom Cancer 10:221-230.
43. Quinlan DC, Davidson AG, Summers CL, Waeden HE, Doshi HM (1992): Accumulation of p53 proteins correlates with a poor prognosis in human lung cancer. Cancer Res 52:4828-4831.
44. Thorlacius S, Börresen AL, Eyfjord JE (1993): Somatic mutations in human breast carcinomas in an Icelandic populations: A prognostic factor. Cancer Res 53:1637-1641.
45. Lowe SW, Ruley HE, Jacks T, Housman DE (1993): p53 dependent apoptosis modulates cytotoxicity of anticancer agents. Cell 74:957-967.